These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2220407)

  • 1. The natriuretic effects of AVP and dDAVP: a lithium clearance study in conscious rats.
    Plange-Rhule J; Atherton JC; Drake R; Kennon S
    Acta Physiol Scand Suppl; 1990; 591():38-9. PubMed ID: 2220407
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
    Ebenezer IS
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):315-21. PubMed ID: 7934310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.
    Matsui K; Kimura T; Ota K; Iitake K; Shoji M; Inoue M; Yoshinaga K
    Endocrinol Jpn; 1985 Aug; 32(4):547-57. PubMed ID: 3936702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallikrein release from the kidney: in vitro effects of AVP and DDAVP in three species.
    Grenfell SJ; Albano JD; Waller DG
    Arch Int Pharmacodyn Ther; 1988; 292():281-5. PubMed ID: 3395173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of vasopressin and its analogs on blood coagulation in rats].
    Golubeva MG; Kalishevskaia TM; Solov'eva ME
    Fiziol Zh (1978); 1990; 36(3):25-30. PubMed ID: 2394244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lysine-vasopressin (LVP) and 1-deamino-8-D-arginine-vasopressin (dDAVP) upon electrical potential, short-circuit current and transepithelial D.C. resistance of the frog skin.
    Bakos P; Ponec J; Lichardus B
    Gen Physiol Biophys; 1984 Aug; 3(4):297-305. PubMed ID: 6094299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine vasopressin potentiates natriuretic effect of atrial peptide.
    Graczak LM; Nicolodi LK; Hartupee DA; Blaine EH
    Am J Physiol; 1989 Mar; 256(3 Pt 2):H925-7. PubMed ID: 2522287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antidiuretic and natriuretic effects of [8-lysine]vasopressin and [8-D-arginine]deaminovasopressin in conscious rats.
    Skopková J; Hrbas R; Barth T
    Endocrinol Exp; 1981; 15(2):129-38. PubMed ID: 6973460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic response to atrial natriuretic factor enhanced by angiotensin II and vasopressin.
    Trippodo NC; MacPhee AA; Cole FE
    J Hypertens Suppl; 1984 Dec; 2(3):S289-91. PubMed ID: 6242556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of dDAVP and AVP on the sodium transport in the frog skin.
    Bakos P; Ponec J; Lichardus B
    Gen Physiol Biophys; 1990 Feb; 9(1):71-81. PubMed ID: 2311915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
    Li Y; Shaw S; Kamsteeg EJ; Vandewalle A; Deen PM
    J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of deamino-8-D-arginine vasopressin on urinary prostaglandins E2 and F2 alpha excretion.
    Walker L; Frölich JC
    Adv Prostaglandin Thromboxane Res; 1980; 7():1107-9. PubMed ID: 7369023
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of arginine vasopressin suppression of ovine fetal lung fluid secretion: lack of V2-receptor effect.
    Albuquerque CA; Nijland MJ; Ross MG
    J Matern Fetal Med; 1998; 7(4):177-82. PubMed ID: 9730483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs.
    Liard JF
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):174-80. PubMed ID: 2452311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cardiovascular reactivity to desmopressin in water-restricted rats: facilitatory role of immunosuppression.
    Tyagi MG; Thomas M
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):619-24. PubMed ID: 10669908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin stimulates the expression of P-selectin on human platelets in vitro.
    Wun T; Paglieroni TG; Lachant NA
    J Lab Clin Med; 1995 Oct; 126(4):401-9. PubMed ID: 7561450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental studies of the liberation of plasminogen activator by DDAVP].
    Jablonowski C; Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):567-74. PubMed ID: 6083928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.